Disclosure processes may interact with reactions to specific test results, which has implications for the wider dissemination of these diagnostics. Assessable characteristics predict large FTP changes post-biomarker disclosure, which may help identify individuals with atypical outcomes.
Stites et al. (Mon,) studied this question.